The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 (Outcomes Study)

ICR 202410-0910-004

OMB: 0910-0915

Federal Form Document

Forms and Documents
Document
Name
Status
Justification for No Material/Nonsubstantive Change
2024-10-18
Supporting Statement B
2024-10-18
Supporting Statement A
2024-10-18
Justification for No Material/Nonsubstantive Change
2024-02-01
Supplementary Document
2024-01-25
Supplementary Document
2022-12-27
Supplementary Document
2022-12-27
ICR Details
0910-0915 202410-0910-004
Received in OIRA 202312-0910-008
HHS/FDA CTP
The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 (Outcomes Study)
No material or nonsubstantive change to a currently approved collection   No
Regular 10/18/2024
  Requested Previously Approved
06/30/2026 06/30/2026
1,131,408 856,316
154,921 115,399
0 0

This proposed information collection supports the U.S. Food and Drug Administration’s (FDA) efforts to assess campaign effectiveness. The Center for Tobacco Products (CTP) is proposing to conduct a quantitative study of the effects of FDA’s The Real Cost campaign on youth in the U.S. The purpose of FDA’s The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 is to evaluate whether changes in key outcomes can be attributed to campaign exposure. We intend to measure self-reported campaign exposure to media advertising, which among many things, will enable FDA to assess its relationship with market-level delivery. The study will be conducted using web-based surveys that are self-administered on personal computers or web enabled mobile devices.

PL: Pub.L. 111 - 31 1 Name of Law: Family Smoking Prevention and Tobacco Control Act
  
None

Not associated with rulemaking

  87 FR 44409 07/26/2022
88 FR 7983 02/07/2023
Yes

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 1,131,408 856,316 0 0 275,092 0
Annual Time Burden (Hours) 154,921 115,399 0 0 39,522 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
We are submitting this change request to update baseline study documents for use in follow-up waves of data collection.

$2,280,544
Yes Part B of Supporting Statement
    Yes
    No
No
No
Yes
No
Amber Sanford 301 796-8867 amber.sanford@fda.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
10/18/2024


© 2024 OMB.report | Privacy Policy